GSK PLC (GSK)
40.32
-0.24
(-0.58%)
USD |
NYSE |
Jun 25, 16:00
40.31
0.00 (0.00%)
After-Hours: 20:00
GSK Research and Development Expense (Annual): 7.743B for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.743B |
| December 31, 2022 | 6.796B |
| December 31, 2021 | 6.905B |
| December 31, 2020 | 6.152B |
| December 31, 2019 | 5.833B |
| December 31, 2018 | 5.194B |
| December 31, 2017 | 5.779B |
| December 31, 2016 | 4.916B |
| December 31, 2015 | 5.440B |
| December 31, 2014 | 5.687B |
| December 31, 2013 | 6.138B |
| December 31, 2012 | 6.305B |
| December 31, 2011 | 6.429B |
| December 31, 2010 | 6.871B |
| December 31, 2009 | 6.431B |
| December 31, 2008 | 6.807B |
| December 31, 2007 | 6.485B |
| December 31, 2006 | 6.372B |
| December 31, 2005 | 5.705B |
| December 31, 2004 | 5.321B |
| Date | Value |
|---|---|
| December 31, 2003 | 4.558B |
| December 31, 2002 | 4.358B |
| December 31, 2001 | 3.689B |
| December 31, 2000 | 3.829B |
| December 31, 1999 | 2.053B |
| December 31, 1998 | 1.928B |
| December 31, 1997 | 1.881B |
| December 31, 1996 | 1.813B |
| December 31, 1995 | 2.431B |
| June 30, 1995 | |
| June 30, 1994 | 1.284B |
| June 30, 1993 | 1.201B |
| June 30, 1992 | 1.047B |
| June 30, 1991 | 881.36M |
| June 30, 1990 | 683.49M |
| June 30, 1989 | 554.32M |
| June 30, 1988 | 403.31M |
| June 30, 1987 | 227.24M |
| June 30, 1986 | 162.74M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
5.833B
Minimum
2019
7.743B
Maximum
2023
6.686B
Average
6.796B
Median
2022
Research and Development Expense (Annual) Benchmarks
| AstraZeneca PLC | 10.94B |
| Haleon PLC | 386.98M |
| Pfizer Inc | 10.68B |
| Sanofi SA | 7.284B |
| Moderna Inc | 4.845B |